1 - 25 of 85 results for author:"Borst P." in Literature citations
Results Customize
› Repeat search in UniProtKB (145)
| Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol. Zander S.A., Kersbergen A., Sol W., Gonggrijp M., van de Wetering K., Jonkers J., Borst P., Rottenberg S. Cancer Prev Res (Phila) 5:1053-1060(2012) · Mapped (2) |
| Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. Rottenberg S., Vollebergh M.A., de Hoon B., de Ronde J., Schouten P.C., Kersbergen A., Zander S.A., Pajic M., Jaspers J.E., Jonkers M. et al. Cancer Res. 72:2350-2361(2012) · Mapped (18) |
| ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxanthoma elasticum. Fulop K., Jiang Q., Wetering K.V., Pomozi V., Szabo P.T., Aranyi T., Sarkadi B., Borst P., Uitto J., Varadi A. Biochem. Biophys. Res. Commun. 415:468-471(2011) · Mapped (7) |
| Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. Krumpochova P., Sapthu S., Brouwers J.F., de Haas M., de Vos R., Borst P., van de Wetering K. FASEB J. 26:738-747(2012) · Mapped (4) |
| Mammalian BTBD12 (SLX4) protects against genomic instability during mammalian spermatogenesis. Holloway J.K., Mohan S., Balmus G., Sun X., Modzelewski A., Borst P.L., Freire R., Weiss R.S., Cohen P.E. PLoS Genet. 7:e1002094-e1002094(2011) · Mapped (51) |
| The structural basis for recognition of base J containing DNA by a novel DNA binding domain in JBP1. Heidebrecht T., Christodoulou E., Chalmers M.J., Jan S., Ter Riet B., Grover R.K., Joosten R.P., Littler D., van Luenen H., Griffin P.R. et al. Nucleic Acids Res. 39:5715-5728(2011) · UniProtKB (1) |
| Mammalian BLM helicase is critical for integrating multiple pathways of meiotic recombination. Holloway J.K., Morelli M.A., Borst P.L., Cohen P.E. J. Cell Biol. 188:779-789(2010) · Mapped (10) |
| Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan. Zander S.A., Kersbergen A., van der Burg E., de Water N., van Tellingen O., Gunnarsdottir S., Jaspers J.E., Pajic M., Nygren A.O., Jonkers J. et al. Cancer Res. 70:1700-1710(2010) · Mapped (30) |
| Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Beedholm-Ebsen R., van de Wetering K., Hardlei T., Nexo E., Borst P., Moestrup S.K. Blood 115:1632-1639(2010) · Mapped (10) |
| Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. Pajic M., Iyer J.K., Kersbergen A., van der Burg E., Nygren A.O., Jonkers J., Borst P., Rottenberg S. Cancer Res. 69:6396-6404(2009) · Mapped (13) |
| Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol. van de Wetering K., Burkon A., Feddema W., Bot A., de Jonge H., Somoza V., Borst P. Mol. Pharmacol. 75:876-885(2009) · Mapped (5) |
| Evidence that J-binding protein 2 is a thymidine hydroxylase catalyzing the first step in the biosynthesis of DNA base J. Vainio S., Genest P.-A., ter Riet B., van Luenen H.G.A.M., Borst P. Mol. Biochem. Parasitol. 164:157-161(2009) · UniProtKB (1) |
| Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Rottenberg S., Nygren A.O., Pajic M., van Leeuwen F.W., van der Heijden I., van de Wetering K., Liu X., de Visser K.E., Gilhuijs K.G., van Tellingen O. et al. Proc. Natl. Acad. Sci. U.S.A. 104:12117-12122(2007) · Mapped (11) |
| Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. van de Wetering K., Zelcer N., Kuil A., Feddema W., Hillebrand M., Vlaming M.L., Schinkel A.H., Beijnen J.H., Borst P. Mol. Pharmacol. 72:387-394(2007) · Mapped (15) |
| Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. Ono N., Van der Heijden I., Scheffer G.L., Van de Wetering K., Van Deemter E., De Haas M., Boerke A., Gadella B.M., De Rooij D.G., Neefjes J.J. et al. Biochem. J. 406:31-40(2007) · Mapped (4) |
| The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase. Yu Z., Genest P.-A., ter Riet B., Sweeney K., DiPaolo C., Kieft R., Christodoulou E., Perrakis A., Simmons J.M., Hausinger R.P. et al. Nucleic Acids Res. 35:2107-2115(2007) · UniProtKB (2) |
| cGMP transport by vesicles from human and mouse erythrocytes. de Wolf C.J., Yamaguchi H., van der Heijden I., Wielinga P.R., Hundscheid S.L., Ono N., Scheffer G.L., de Haas M., Schuetz J.D., Wijnholds J. et al. FEBS J. 274:439-450(2007) · Mapped (38) |
| The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Breedveld P., Pluim D., Cipriani G., Dahlhaus F., van Eijndhoven M.A., de Wolf C.J., Kuil A., Beijnen J.H., Scheffer G.L., Jansen G. et al. Mol. Pharmacol. 71:240-249(2007) · Mapped (5) |
| Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Manautou J.E., de Waart D.R., Kunne C., Zelcer N., Goedken M., Borst P., Elferink R.O. Hepatology 42:1091-1098(2005) · Mapped (4) |
| Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. Zelcer N., van de Wetering K., de Waart R., Scheffer G.L., Marschall H.U., Wielinga P.R., Kuil A., Kunne C., Smith A., van der Valk M. et al. J. Hepatol. 44:768-775(2006) · Mapped (4) |
| Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Zelcer N., van de Wetering K., Hillebrand M., Sarton E., Kuil A., Wielinga P.R., Tephly T., Dahan A., Beijnen J.H., Borst P. Proc. Natl. Acad. Sci. U.S.A. 102:7274-7279(2005) · Mapped (19) |
| Formation of linear inverted repeat amplicons following targeting of an essential gene in Leishmania. Genest P.-A., ter Riet B., Dumas C., Papadopoulou B., van Luenen H.G.A.M., Borst P. Nucleic Acids Res. 33:1699-1709(2005) · UniProtKB (1) |
| Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. Assem M., Schuetz E.G., Leggas M., Sun D., Yasuda K., Reid G., Zelcer N., Adachi M., Strom S., Evans R.M. et al. J. Biol. Chem. 279:22250-22257(2004) · Mapped (13) |
| Base J, found in nuclear DNA of Trypanosoma brucei, is not a target for DNA glycosylases. Ulbert S., Eide L., Seeberg E., Borst P. DNA Repair (Amst.) 3:145-154(2004) · UniProtKB (5) |
| The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., Wijnholds J., Borst P. Proc. Natl. Acad. Sci. U.S.A. 100:9244-9249(2003) · Mapped (8) |